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Abstract 
In the present investigation, a statistical analysis was conducted to evaluate 
the production of scientific papers in the fields of Pharmacology, Toxicology 
and Pharmaceutical during a period of 1996-2007. The study identified the 
most active countries in the Middle East in comparison with some more 
developed countries, in which the most scientific impacts have been exerted. 
Our screenings through the most accessed data bases revealed that USA, 
Japan, UK and Germany are the leading countries regarding scientific 
publications and citations, since 51% of all citable-publications and 58% of 
total citations in the subject area belong to these scientifically prolific 
countries. The contribution of different world region during the studied 
period was: Western Europe (34.10%), Northern America (31.40%), Asiatic 
Region (21.50%), Eastern Europe (4.60%), Pacific Region (2.20%), Middle 
East (1.90%), Southern Africa (0.40%), Central Africa (0.30%), and Northern 
Africa, (0.10%). Within Middle-East region, Islamic Republic of Iran has 
produced 21.5% of total citable-publication and 13.7% citations, while such 
values for Egypt are 23% and 17.4%, respectively. A significant increase in 
scientific trend of the related subjects by Iranian scientists not only reveals a 
rapid and substantial growth of the number of scientific publications but also 
highlights the impacts of Iranian scientists within world scientific 
community. 
Keywords: Pharmacology, Toxicology, Pharmaceutical, publication, 
Scientific output, Citation, Iran.   
 
Introduction 
In the era of third millennium, information and 
knowledge are going to become the main capitals of 
mankind.  Such resources are deemed to play a key 
role in terms of international rules and regulations 
from politic, economic and scientific view points. In 
fact, there exist a direct relationship between the 
economic advances and improvements with scientific 
production even though scientific productions are 
somehow contingent upon economical/political 
situations. For prophesy of scientific impacts, we 
need to investigate the profile of scientific 
achievements using subject-wise careful procedures. 
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The most general policy implication is that today 
scientific societies experiencing rapid growth of 
scientific data, which definitely needs to be 
scientometrically evaluated by screening the growth 
profiles of the target subject within decades to get 
reliable corollaries.  
In this strategic region of globe, we perceive 
enhanced prolific outcomes for good sciences despite 
the cost of education in higher level which is 
considerably being exacerbated with 
endogenous/exogenous political/economical problems 
resulting in increased brain drain form this region 
towards more developed countries. For example, the 
Islamic Republic of Iran has the highest rate of "brain 
drain" among 61 "developing" and "less developed" 
countries according to the International Monetary 
Fund. Regardless of these burdens that result in 
awkward scientific state, in this current study, we 
aimed to look at the scientific production profile of 
pharmacology, toxicology and pharmaceutics 
domains within the Middle-East region to highlight 
the scientific impacts of Iranian scientists. This will 
directly and globally represent the role of Iranian 
scientists in the scientific community even though the 
country itself has being under political sanction that 
has exerted a direct influence on the Iranian scientists 
productivities.  
 Methodology 
To measure the quantity and quality of science in the 
subject area of "Pharmacology, Toxicology and 
Pharmaceutics", 20 top prolific countries were 
compared with the Middle-East countries. All data 
was extracted from The SCImago database 
(http://www.scimagojr.com/), which is based on 
Scopus data-base. These data represent scientific 
information from more than 17,087 journals. Only 
citable-publications were taken under consideration. 
We made comparison across 20 more active countries 
as well as Middle-East countries. Data about the 
number of populations were extracted from U.S. 
Census Bureau, Population Division 
(http://www.census.gov/ipc/www/idb/). 
 
Findings: 
Table 1: Number of Publications for 20 top active 
countries in the subject area of Pharmacology, 
Toxicology and Pharmaceutics 1996-2007 
Table 1: Number of Publications for 20 top active countries 
in the subject area of Pharmacology, Toxicology and 
Pharmaceutics 1996-2007 
Ranked by 
Productivity 
(Publication) 
Country Publica-tions Citations 
Citation per 
Publication 
1 USA 108,592 1,613,027 14.81 
2 Japan 36,807 355,724 9.45 
3 UK 26,393 415,913 14.76 
4 Germany 23,545 266,668 11.08 
5 China 19,343 72,637 4.57 
6 France 15,541 203,858 12.92 
7 Italy 15,012 184,677 12.66 
8 Canada 12,736 186,479 14.8 
9 India 10,743 64,803 6.8 
10 Spain 9,168 94,493 10.25 
11 Netherlands 8,522 105,986 12 
12 Australia 7,183 84,394 11.44 
13 
Korea 
(Republic) 6,950 56,004 9.24 
14 Brazil 6,307 45,722 8.86 
15 Sweden 5,760 97,762 16.82 
16 Switzerland 5,276 96,458 18.56 
17 Poland 5,146 34,955 6.91 
18 Belgium 4,594 61,404 13.62 
19 Taiwan 4,175 39,508 10.14 
20 Turkey 3,969 25,125 6.6 
Table 1 shows total number of citable-publications for 
20 top productive countries and their citations share 
in The SCImago. As the table indicates the USA 
heads the list of countries in the volume of citable-
publications and citations in the subject area of 
Pharmacology, Toxicology and Pharmaceutical. The 
following countries are Japan, UK and Germany.  
 
Since the number of publications does not usually 
represent the quality of the research, we have also 
looked at the citations per publication that 
demonstrates the worthiness of the research work to 
other scientists. It is assumed that the citation 
frequency of an article normally mirror its value and 
usefulness. "When a physician or a biomedical 
researcher cites a journal article, it indicates that the 
cited journal has influenced him or her in some 
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manner." [Garfield 1987, p. 7]. The number of 
publications in China is high and this country has 
been ranked as the fifth top country (Table 1), 
however when the analysis comes to the citations per 
publication the rank of this country drops 
dramatically down. As shown in Table 1, in this 
ranking China is the 20th country, while Switzerland 
has achieved much higher ranking place (the 1st rank). 
Comparing this small but high scientific impact 
country with leading countries such as USA, UK and 
Japan, it is clear that the quality and/or the orientation 
of the science in this country is in high and in right 
track.   
 
Fig. 1: Number of citations per publication for 20 
most active countries 1996-2007   
Number of citations per Publication for 20 active countries 
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The figure shows the rank of countries based on their 
citations per paper; only the 20 top productive 
countries were taken under consideration. Switzerland 
with possessing 18.6 citations per publication get the 
first place on the ranking following Sweden (16.8 
citations per paper), USA (14.8 citations per paper), 
and Canada (14.8 citations per paper). In terms of 
citation per paper, the European countries as well as 
English language countries are at the top ranks of lists 
in the figure.  The Asian countries are at 13 (Taiwan), 
14 (Japan), 15 (Korea), 18 (India) and the last one is 
China; where as their corresponding rank in term of 
publications (Table1) are 2 (Japan), 5 (China), 9 
(India), 13(Korea) and 19 (Taiwan) 
Table 2: Number of publications from Middle East 
provided in SCImago 1996-2007 
 
According to the information of table 2, Israel with 
producing 46% of total citable-publications and 73% 
of total citations coming from Middle East, is the 
most productive country in the region following Iran 
(17% publications and 7% citations) and Egypt (14% 
of total publications and 8% of citations) through 
1996-2007. On behalf of countries H-Index Israel is 
more than 2 times greater than Iran and Egypt.  
 
Table 2: Number of publications from Middle East 
provided in SCImago 1996-2007 
 
R 
A 
N 
K 
Country Publica- tions Citations 
Self- 
Citations 
Citations 
Per 
Publication 
H 
index 
1 Israel 2,203 30,172 5,142 13.9 64 
3 Egypt 1,671 10,502 2,174 6.62 32 
2 Iran 1,592 8,268 2,999 6.98 29 
4 Saudi 923 4,996 776 5.36 28 
5 Jordan 312 1,638 228 5.62 20 
6 Emirate 221 1,290 187 6.25 18 
7 Kuwait 216 1,498 240 7.6 18 
8 Lebanon 116 1,163 168 14.7 19 
10 Qatar 36 101 18 5.76 5 
9 Oman 33 142 21 6.05 6 
11 Palestine 27 139 14 6.11 5 
12 Iraq 20 136 12 7.16 6 
13 Yemen 19 153 18 8.88 7 
14 Syria 18 88 14 6.29 6 
15 Bahrain 14 23 4 2.47 3 
 
The Figure shows the number of publications of four 
active countries in Middle East in the subject area of 
Pharmacology, Toxicology and Pharmaceutics 
through 1996-2007. 
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Fig. 2:  Number of publications of 4 countries in Middle East 
1996-2007 
 
It indicates that there has been significant growth in 
the Research literature on Pharmacology, Toxicology 
and Pharmaceutics in Middle East countries. The 
literature of science contributed by Iranian authors 
since 1996 till 2001 stand under other 4 countries, but 
from 2002 take a sharp raise and since 2005 with an 
exponential growth ahead all countries and placed at 
the first place in the region. In 2007 the number of 
publications emanated by Iranian authors is 5 times 
greater than in 2001. The number of scientific 
literature produced by Iranian authors in 2007 is 48% 
greater than the publications emanated by authors 
from Israel.  
 
Table 3: Number of publications form Iran 
 
Years No. of 
Publications 
% of 
Publications 
1996-1999 211 13% 
2000-2003 352 22% 
2004-2007 1029 65% 
Total 1592 100% 
 
The number of publication in the field of 
Pharmacology, Toxicology and Pharmaceutics by 
Iranian authors accurately can be divided in 3 phases. 
As the Table indicates the most active phase of 
Iranian author publishing scientific literature in the 
field of Pharmacology, Toxicology and 
Pharmaceutics is 2004-2007. From a total number of 
1,592 publications, provided by Iranian authors in 
SCImago 1,029 (65%) of them was produced during 
these years. 
 
Table 4: Number of publications per million 
populations for countries in SCImago 1996-2007 
 
Rank Country 
Mean Value 
of Population 
1996-2007 
No. of Citable 
Publications 
Publication 
per million 
population 
1 Switzerland 7,349 5,276 718 
2 Sweden 8,952 5,760 643 
3 Netherlands 16,058 8,522 531 
4 Belgium 10,293 4,594 446 
5 UK 59,759 26,393 442 
6 Canada 31,485 12,736 405 
7 USA 285,937 108,592 380 
8 Australia 19,431 7,183 370 
9 Israel 6,283 2,203 351 
10 Japan 126,879 36,807 290 
11 Germany 82,242 23,545 286 
12 Italy 57,828 15,012 260 
13 France 61,719 15,541 252 
14 Spain 40,122 9,168 229 
15 Poland 38,612 5,146 133 
16 Kuwait 2,086 216 104 
17 Jordan 4,927 312 63 
18 
United 
Arab 
Emirates 3,492 221 63 
19 Turkey 68,924 3,969 58 
20 Qatar 677 36 53 
21 
Saudi 
Arabia 24,130 923 38 
22 Brazil 180,094 6,307 35 
23 Lebanon 3,656 116 32 
24 Iran 63,578 1,592 25 
25 Egypt 67,467 1,671 25 
26 Bahrain 650 14 22 
27 China 1,278,350 19,343 15 
28 Oman 2,684 33 12 
29 India 1,031,503 10,743 10 
30 Syria 17,223 18 1 
31 Yemen 18,335 19 1 
32 Iraq 23,736 20 1 
 
Ranking the countries activity based on publication 
per million population we see that Switzerland ahead 
all countries following Sweden and Netherlands. The 
USA in spite of producing the majority of related 
publications places on the seventh in the ranking. Iran 
located in the 24th place of ranking. 
 
Table 5: Total citable publication in the Subject 
Area of (Pharmacology, Toxicology and 
Pharmaceutics) in the SCImago 1996-2007. 
 
R 
A 
N 
K 
Country 
Citable 
Publica-
tions 
percent 
world Citations 
Percent 
world 
1 U.S.A. 
108,59
2 28.09 1,613,027 
35.48
% 
2 Japan 36,807 9.52 355,724 7.82% 
3 U.K. 26,393 6.83 415,913 9.15% 
4 Germany 23,545 6.09 266,668 5.87% 
5 China 19,343 5.00 72,637 1.60% 
6 France 15,541 4.02 203,858 4.48% 
7 Italy 15,012 3.88 184,677 4.06% 
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8 Canada 12,736 3.29 186,479 4.10% 
9 India 10,743 2.78 64,803 1.43% 
10 Spain 9,168 2.37 94,493 2.08% 
11 Netherlands 8,522 2.20 105,986 2.33% 
12 Australia 7,183 1.86 84,394 1.86% 
13 
Korea, 
Republic Of 6,950 1.80 56,004 1.23% 
14 Brazil 6,307 1.63 45,722 1.01% 
15 Sweden 5,760 1.49 97,762 2.15% 
16 Switzerland 5,276 1.36 96,458 2.12% 
17 Poland 5,146 1.33 34,955 0.77% 
18 Belgium 4,594 1.19 61,404 1.35% 
19 
Taiwan, 
Province of 
China 4,175 1.08 39,508 0.87% 
20 Turkey 3,969 1.03 25,125 0.55% 
21 
Russian 
Federation 2,981 0.77 12,115 0.27% 
22 Denmark 2,834 0.73 40,625 0.89% 
23 Finland 2,705 0.70 39,187 0.86% 
24 Hungary 2,451 0.63 21,422 0.47% 
25 Austria 2,395 0.62 30,239 0.67% 
26 Mexico 2,235 0.58 15,734 0.35% 
27 Israel 2,203 0.57 30,172 0.66% 
28 Greece 2,126 0.55 15,859 0.35% 
29 Argentina 1,823 0.47 13,427 0.30% 
30 Egypt 1,671 0.43 10,502 0.23% 
31 
Czech 
Republic 1,655 0.43 12,536 0.28% 
32 Hong Kong 1,598 0.41 17,829 0.39% 
33 Iran 1,592 0.41 8,268 0.18% 
34 Norway 1,492 0.39 19,231 0.42% 
35 
New 
Zealand 1,401 0.36 14,172 0.31% 
36 Portugal 1,299 0.34 13,247 0.29% 
37 Ireland 1,050 0.27 14,938 0.33% 
38 Croatia 1,039 0.27 4,356 0.10% 
 
USA with entering 28% of world publications in 
SCImago is the leading country, from a total number 
of 386,625 publications provided in SCImago 
108,592 (28%) came from the USA, 36,807 (10%) 
from Japan, 26,393 (7%) from UK, and 23,545 (6%) 
from Germany. The portion of three active countries 
from Middle East is as follow: Israel 2,203 (0.57%), 
Egypt 1,671 (0.43%) and Iran 1,592 (0.41%).  
A total number of 386,625 citable publications came 
from 185 countries. 96% (370,312) of total 
publications originated by 38 countries, which listed 
in the table 5; the rest countries (147 countries) 
published only 4% of total publications, which were 
not listed in the table.  The table restricted to the 
countries whose publications’ share in the subject 
area of Subject Area: Pharmacology, Toxicology and 
Pharmaceutics were higher than 1,000 publications. 
 
Table 6: Total citable Publications by Iranian authors in 
SCImago 1996-2007 
Years Total citable 
Publications 
Percentage 
1996 – 1999 4229  9% 
2000 – 2003 10139 20% 
2004 - 2007 35282 71% 
Total 49650 100% 
The number of publications emanated by Iranian 
authors through 2004-2007 is 146% higher than those 
published through 1996-2003. One can say that the 
most active phase of Iranian authors sharing their 
publications and citations is this phase. 
 
Table 7: total number of publications in the field of 
(Pharmacology, Toxicology and Pharmaceutics) from 
regions in SCImago 1996-2007 
Rank Region publication percentage 
1 Western Europe  131,943 34.10% 
2 Northern America. 121,328 31.40% 
3 Asiatic Region. 83,106 21.50% 
4 Eastern Europe  17,646 4.60% 
5 Latin America. 13,354 3.50% 
6 Pacific Region 8,666 2.20% 
7 Middle East  7,421 1.90% 
8 Southern Africa  1,424 0.40% 
9 Central Africa. 1,229 0.30% 
10 Northern Africa  508 0.10% 
 Total 386,625 100.00% 
 
From total number of 386,625 publications through 
the period of study more than 65% came from 
Western Europe and Northern America. These two 
regions are also the leading countries sharing the 
citations in the fields (Table 8). The portion of Middle 
East is only 1.90%.   
 
Table 8: Number of citations sharing by regions in 
the SCImago 1996-2007 
Rank Region  Citation Percentage 
1 Northern America. 1,799,506 39.60% 
2 Western Europe  1,729,229 38.00% 
3 Asiatic Region. 633,492 13.90% 
4 Eastern Europe  108,333 2.40% 
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5 Pacific Region 99,107 2.20% 
6 Latin America. 95025 2.10% 
7 Middle East  60,309 1.30% 
8 Southern Africa  12,986 0.30% 
9 Central Africa. 5,026 0.10% 
10 Northern Africa  3,506 0.10% 
 Total 4,546,519  100.00% 
 
Table 9: Number of publications and citations 
provided in SCImago from Middle East countries 
1996-2007 
Rank Country 
Publica- 
tions 
Percen
-tage Citations 
Percent-
tage 
1 Israel 2,203 30% 30,172 50.0% 
2 Egypt 1,671 23% 10,502 17.4% 
3 Iran 1,592 21.5% 8,268 13.7% 
4 
Saudi 
Arabia 923 12.4% 4,996 8.3% 
5 Jordan 312 4.2% 1,638 2.7% 
6 
United 
Arab 
Emirates 221 3.0% 1,290 2.1% 
7 Kuwait 216 2.9% 1,498 2.5% 
8 Lebanon 116 1.6% 1,163 1.9% 
9 Qatar 36 0.5% 101 0.2% 
10 Oman 33 0.4% 142 0.2% 
11 Palestine 27 0.4% 139 0.2% 
12 Iraq 20 0.3% 136 0.2% 
13 Yemen 19 0.3% 153 0.3% 
14 Syria 18 0.2% 88 0.1% 
15 Bahrain 14 0.2% 23 0.0% 
 Total 7,421  60,309  
 
Israel is the most active country throughout the period 
of study, following Egypt and Iran. More than 74% of 
all publications in the region came from Israel, Egypt 
and Iran. 
 
Conclusion: 
The study showed that Pharmacology, Toxicology 
and Pharmaceutics research in Iran is increasing, it 
can be said that Iranian researchers in the fields 
published around 133 literature of science per year 
which indexed in the database. Worldwide trend of 
papers showed that the Pharmacology, Toxicology 
and Pharmaceutics research work is being done on 
world wide basis. The USA is the largest producer of 
Pharmacology, Toxicology and Pharmaceutical 
related papers, following countries are Japan, UK and 
Germany. The top 20 prolific countries are (U.S.A., 
Japan, U.K, Germany, China, France, Italy, Canada, 
India, Spain, Netherlands, Australia, Korea, Brazil, 
Sweden, Switzerland, Poland, Belgium, Taiwan, and 
Turkey). This group accounted of about 87% of total 
publications and more than 90% of total citations in 
the fields. 
 
 
Significant growth in the Research literature on 
Pharmacology, Toxicology and Pharmaceutics has 
been done in Middle East countries. Israel is the most 
active country producing related papers and sharing 
the citations following Egypt and Iran through the 
period of study. The literature of science contributed 
by Iranian authors during 1996-2001 was smaller than 
Israel, Egypt and Saudi Arabia, but from 2005 take an 
increasingly effort so that ahead all countries in the 
region. The numbers of Iranian Publications in the 
subject area in 2007 was 113% greater then in 2004. 
Tendency towards self-citation by Iranian authors is 
greater than other active countries in the region. 
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